Skip to main content
. 2016 Feb 8;13(2):428–438. doi: 10.1007/s13311-016-0420-z

Table 4.

Expanded Disability Status Scale

Time Placebo treatment (n = 14) um-PEA treatment (n = 15)
1 month 2.3 ± 1.0 1.7 ± 0.9
3 months 2.2 ± 1.0 1.5 ± 0.9
6 months 2.3 ± 0.9 1.6 ± 0.8
9 months 2.4 ± 1.0 1.6 ± 0.8
12 months 2.5 ± 1.0 1.8 ± 1.2

Results are reported as mean ± SD

um-PEA = ultramicronized palmitoylethanolamide